MAGELLAN HEALTH,INC. (NASDAQ:MGLN) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition
On April 26, 2017, Magellan Health, Inc. (the Company) reported
operating results for the quarter ended March 31, 2017 and
confirmed its guidance for 2017.
Attached and incorporated herein by reference as Exhibit 99.1 is
a copy of the press release dated April 26, 2017.
Item 9.01. Financial Statements, Pro Forma Financial Information
and Exhibits
(a) Financial Statements of business acquired: Not applicable.
(b) Pro forma financial information: Not applicable.
(d) Exhibits:
|
7 |
|
|
Exhibit Number |
Description |
|
99.1 |
Registrants press release dated April26, 2017. |
2
About MAGELLAN HEALTH, INC. (NASDAQ:MGLN)
Magellan Health, Inc. is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs). MAGELLAN HEALTH, INC. (NASDAQ:MGLN) Recent Trading Information
MAGELLAN HEALTH, INC. (NASDAQ:MGLN) closed its last trading session 00.00 at 71.70 with 138,315 shares trading hands.
